1. Home
  2. KEQU vs VTVT Comparison

KEQU vs VTVT Comparison

Compare KEQU & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$37.62

Market Cap

124.6M

Sector

Industrials

ML Signal

N/A

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$41.84

Market Cap

127.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
VTVT
Founded
1906
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
127.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
KEQU
VTVT
Price
$37.62
$41.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$51.33
AVG Volume (30 Days)
7.5K
14.6K
Earning Date
12-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$17,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.76
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$13.20
52 Week High
$71.33
$43.08

Technical Indicators

Market Signals
Indicator
KEQU
VTVT
Relative Strength Index (RSI) 45.04 78.62
Support Level $37.10 $38.22
Resistance Level $38.29 $41.49
Average True Range (ATR) 1.04 2.39
MACD 0.09 0.47
Stochastic Oscillator 34.22 97.62

Price Performance

Historical Comparison
KEQU
VTVT

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.

Share on Social Networks: